Allogeneic HCT Using Uniform Conditioning Regimen Regardless of Donors (MS, MU, or HF) for AML in Remission

Inclusion Criteria: * Patients with non-promyelocytic AML (intermediate-risk or high-risk diseases by NCCN guideline 2016) in the first CR * Patients should be 16 years of age or more and 75 years of age or less * The performance status of the patients should be 70 or over by Karnofsky performance scale * Patients should have adequate hepatic function (bilirubin less than 2.0 mg/dl, AST less than three times the upper normal limit) * Patients should have adequate renal function (creatinine less than 2.0 mg/dl) * Patients should have adequate cardiac function (ejection fraction \> 40% on MUGA scan) * Patients and stem cell donors must sign informed consent * For hematopoietic cell donor, if a patient has an HLA-matched sibling (65 years or younger), that sibling will be a cell donor. If a patient does not have an HLA-matched sibling but an HLA-A, B, C, DRB1 7-8/8 matched unrelated donor, the unrelated donor will be a cell donor. If a patient has neither HLA-matched sibling nor unrelated donor, an HLA-haploidentical familial donor will be a cell donor.